BioMedWire Stocks Archives - Page 3 of 82

ThursdayJul 02, 2026 10:00 am

Comprehensive Review Shows Gut Microbiome Influences Immunotherapy Efficacy

Scientists have for long been concerned about why some people with liver cancer respond when given immunotherapy but others don’t. A recent comprehensive review provides key insights linking how patients respond to these treatments to the status of their gut microbiome. The review, published in the journal Cancer Biology and Medicine, was conducted by a team based at the Chinese University of Hong Kong. The scientists compiled recent scientific data detailing how the microbial composition of the gut impacts how different patients respond when they are given immune checkpoint blockade therapies against hepatocellular carcinoma, the most common type of liver cancer. They found that anti-tumor immune activity is modulated or influenced…

TuesdayJun 30, 2026 10:00 am

Currently Approved Drug Could Boost Immunotherapy Against Liver Cancer

Researchers at University of Washington have discovered that a drug that is currently approved by the FDA could help in boosting the efficacy of immunotherapy against a rare type of liver cancer that has previously been unresponsive to checkpoint inhibitors. The preclinical study, whose findings appeared in the Gastroenterology journal, found that fibrolamellar carcinoma, an aggressive type of liver cancer, alters normal liver cells and causes them to produce the fibrous tissue that is characteristic of this type of cancer. T-cells that are meant to fight the cancer are then rechanneled into these fibrous bands and trapped there. As a result of this entrapment, the body’s immune…

FridayJun 26, 2026 10:00 am

US Health Care Expenditure Spiked to Nearly $6 Trillion in 2025

According to recent data released by CMS actuaries, spending on health care in the U.S. jumped to $5.7tn in 2025, the third consecutive year in which spending growth exceeded 7%. The data shows that one of the key drivers of this spike was pricey medications, such as GLP-1s, medications used to treat obesity. CMS actuaries note that this growth in spending stems from a number of factors that include people seeking more care and the uptake of expensive medications like the weight loss drugs mentioned earlier. Cost increases accounted for just a small fraction of this expenditure spike. Jacqueline Fiore, an economist working in the actuarial…

ThursdayJun 25, 2026 10:00 am

Researchers Urge Caution in Using Antibiotic Prophylaxis

The medical community has for long relied on antibiotic prophylaxis, the practice of prescribing antibiotics to safeguard at-risk individuals from bacterial infections. However, a new publication has sounded the alarm on the widespread use of these “just in case” treatments due to their risk of driving antibiotic resistance. The paper, published by researchers at Charles University in Prague, appeared in the Clinical Microbiology & Infection journal. The authors caution that the prophylactic use of antibiotics has become unsustainable due to its growing use by medical practitioners because it threatens the long term efficacy of these medications. As more people use these therapies, the risk of antimicrobial resistance is growing,…

TuesdayJun 23, 2026 10:00 am

WashU Vaccine Could Revolutionize Personalized Glioblastoma Treatment

Researchers at Washington University (WashU) Medicine have conducted a small clinical trial testing a new vaccine against glioblastoma. The formulation was administered to nine patients who had undergone surgery and chemo-radiation therapy to remove their tumors. The results of this study show promise in extending tumor-free survival for a disease that is currently hard to treat. The study, whose findings appeared in Nature Cancer, sought to test a novel DNA platform that designs a personalized vaccine aimed at preventing glioblastoma tumors from recurring. Glioblastoma grows aggressively and patients rarely survive for more than a year or two after diagnosis, and scientists have been racing to develop new treatments that…

MondayJun 22, 2026 10:00 am

Why Men Need Sexual Health Help While Undergoing Cancer Treatment

About 90% of men that undergo prostate cancer treatment, and almost 50% of men treated for different kinds of cancer suffer a degree of sexual dysfunction or erectile challenges. Most hardly ever open up about these issues and they suffer in silence. This needn’t be so, because there are many ways through which sexual challenges can be addressed for men with cancer. Cancer treatment is taxing on the body. For example, radiation and chemotherapy can leave patients feeling nauseous and fatigued, which can affect sexual performance. Surgical procedures like those undertaken to manage prostate cancer can also damage nerves, causing sexual problems to arise. Most men don’t receive adequate sexual education…

ThursdayJun 18, 2026 10:00 am

CMS Issues Final Rules on Medicaid Eligibility Work Requirements

Last year, Congress passed changes to Medicaid eligibility requirements and CMS was given a deadline to issue final rules on those work requirements. The federal agency has since published those final rules and enrollees on the Medicaid program need to acquaint themselves with these requirements to ensure they comply in order to retain their eligibility. We discuss some of those requirements. The rules, published on June 1, aren’t going to affect every person enrolled on Medicaid. Instead, they will affect individuals whose coverage is in the category of Medicaid expansion. This program is offered in some, but not all, states around the country. Under Medicaid expansion, adults who earn a low income…

FridayJun 12, 2026 10:00 am

Study Links TBI to Higher Mortality Risk Due to Brain Cancer

A study conducted by a team at Mass General Brigham has found that people with a history of traumatic brain injury had a higher chance of dying as a result of brain cancer. The findings create an urgency to rethink how TBI cases are handled not just in the immediate aftermath but also over the long term. The study, whose findings were published in the journal Neuroepidemiology, analyzed a national database of more than 20,000 patients who had been treated for traumatic brain injury over a period of 37 years (1987–2024). The investigators were especially interested in finding out how a history of TBI impacted mortality risk in brain cancer,…

ThursdayJun 11, 2026 10:00 am

FIU Researchers Discover New Way of Extending Immune Cell Lifespan and Effectiveness

CAR-T therapy has been transformational in treating many blood cancers, such as leukemia and lymphoma. However, this treatment approach hasn’t worked for solid tumors, and it also reaches a point and becomes ineffective in blood cancers. A new study just found a way to boost the lifespan and efficacy window of these important immune cells that help fight cancer. The study, whose findings appeared in the journal Frontiers in Immunology, was conducted by a team at Florida International University (FIU). The researchers spent about five years studying why cancer-fighting immune cells lose their effectiveness and don’t survive for long. They were particularly interested in establishing how tumor cells develop a protective mechanism against the immune cells…

TuesdayJun 09, 2026 10:00 am

Hospitals Take the Lead in Tackling Health Care Access and Affordability

Hospitals have come under the spotlight as public concern about the health care cost crisis reaches unprecedented levels. The president of the American Hospital Association (AHA) wrote an article last week outlining how hospitals are taking steps to ensure that access and affordability issues are addressed so that Americans can continue to enjoy the high quality of care that they have come to expect from the health care system. Rick Pollack explained that hospitals face numerous challenges, such as having to absorb a sizeable fraction of the increasing cost of providing medical services to Americans. This comes as reimbursements for programs like Medicare and Medicaid haven’t risen…